Yibin Kang and Minhong Shen (IMAGE)

Princeton University

Yibin Kang and Minhong Shen — Caption

A new cancer therapy from Yibin Kang’s lab holds potential to switch off major cancer types without side effects. In mice and in human tissue, a new compound discovered by Princeton University Professor Yibin Kang (left) and postdoctoral researcher Minhong Shen (right) disables a key gene (MTDH, or metadherin) that’s implicated in breast, prostate, liver, lung, colon and other cancers.

Credit

Photo by Flynn Larsen for Ludwig Cancer Research

Usage Restrictions

Editorial use only

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.